AI-powered drug company spun out of Google’s DeepMind says human trials are ‘very close’ After years of development, Isomorphic Labs says its AI-created drugs are nearly ready for human trials.

Alphabet’s Isomorphic Labs, spun out of DeepMind, is preparing to start human trials of AI-designed drugs after raising $600 million.

A New Era of Research with Health Studio Clinical trials are the backbone of medical advancement but they’ve historically ...

Google DeepMind’s spin-off Isomorphic Labs says it’s almost ready to begin human testing for AI-designed drugs. Built on the success of AlphaFold, the company aims to speed up drug development in ...

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

A secretive, Google-backed lab is using artificial intelligence to invent new medicines for humanity's worst illnesses. But can we trust drugs designed by a mind that isn't human?

Google DeepMind is getting ready to begin human testing of drugs developed using artificial intelligence. All you need to know ...

Isomorphic Labs, a subsidiary of Alphabet Inc., is close to human trials for its AI-designed medicines. Other companies are also racing to use AI in drug discovery.

It’s a sentiment felt widely across the medical field as AI starts to touch nearly every corner of medical research, physician training and processes, and patient care. The rollout of AI across health ...

Imagine a world without disease. Sounds utopian? AI just made it a multibillion-dollar bet to discover drugs – and forget Big ...

As usual, the one-two punch of ASCO and BIO set us a bit behind, but never fear – your June hires round-up is here at least ...

A Chinese man with no medical training is injecting cancer patients with a toxic bleach solution; a full course of treatment ...